Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic drug approvals this year is 90% higher compared to the fiscal year of 2014.
Throughout the fiscal year of 2018, the US regulator approved 781 generic drugs, topping the previous year’s total of 763, according to PwC’s Health Research Institute. Three years earlier in 2014, the agency approved 409 generic treatments, and 651 in 2016, showing a marked improvement year on year.
Reageer